Evidence map›Paper›PMID 28122556›Full record

ArticleBMC complementary and alternative medicine2017

Therapeutic effects of Qian-Yu decoction and its three extracts on carrageenan-induced chronic prostatitis/chronic pelvic pain syndrome in rats.

Keda Zhang, Xiaobin Zeng, Yonggang Chen, Rong Zhao, Hui Wang, Jinhu Wu

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Keda ZhangDepartment of Pharmacy, Wuhan Third Hospital, Wuhan, People's Republic of China.
Xiaobin ZengCentral Laboratory of Longhua Branch, Shenzhen People's Hospital, Second Clinical Medical College, Jinan University, Shenzhen, People's Republic of China.
Yonggang ChenDepartment of Pharmacy, Wuhan Third Hospital, Wuhan, People's Republic of China.
Rong ZhaoClinical Laboratory, Wuhan Third Hospital, Wuhan, People's Republic of China.
Hui WangDepartment of Pathology, Wuhan Third Hospital, Wuhan, People's Republic of China.
Jinhu WuDepartment of Pharmacy, Wuhan Third Hospital, Wuhan, People's Republic of China. wujinhuyx@sina.com.
Wuhan Third Hospital · CNJinan University · CN

Funding

Wellcome Trust FC001045
6 · The paper itself

Abstract

backgroundQian-Yu decoction (QYD) is a traditional Chinese medicinal recipe composed of Radix astragali (Astragalus membranaceus (Fisch.) Bunge var. mongholicus (Bunge) P.K. Hsiao, Fabaceae ), Herba epimedii (Epimedium brevicornum Maxim., Berberidaceae), Herba leonuri (Leonurus japonicus Houtt., Lamiaceae), Cortex phellodendri (Phellodendron chinense Schneid., Rutaceae) and Radix achyranthis bidentatae (Achyranthes bidentata Bl., Amaranthaceae). This study aimed to evaluate the therapeutic activity of QYD against carrageenan-induced chronic prostatic/chronic pelvic pain syndrome (CP/CPPS) in rats and further elucidate its effective components.

methodsThree types of components, total polysaccharides, total flavonoids and total saponins were separately extracted from QYD. Carrageenan-induced CP/CPPS rats were intragastrically administered with lyophilized product of QYD, individual extracts and all the combined forms of extracts for three weeks. Prostatic index (PI) was determined and histopathological analysis was performed. The levels of tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), cyclooxygenase-2 (COX-2) and prostaglandin E2 (PEG2) in rat prostate tissues were measured using ELISA. The production of inducible nitric oxide synthase (iNOS) was evaluated by an enzymatic activity assay, and the release of nitric oxide (NO) was determined by a nitrate/nitrite assay.

resultsTreatment with QYD significantly ameliorated the histological changes of CP/CPPS rats and reduced the PI by 44.3%, with a marked downregulation of TNF-α (42.8% reduction), IL-1β (45.3%), COX-2 (36.6%), PGE2 (44.2%), iNOS (54.1%) and NO (46.0%). Each of three extracts attenuated the symptom of CP/CPPS, but much more weakly than QYD. The combined administration of three extracts showed efficacy comparable to that of QYD while better than that of any combination of two extracts. A principal component analysis of the six inflammatory mediators as variables indicated that the effects of TS on CP/CPPS were rather different from those of TF and TP, which were similar.

conclusionsQYD can be beneficial in prevention and treatment of CP/CPPS. Polysaccharides, flavonoids and saponins, as the major effective components of QYD, exert a cooperative effect on CP/CPPS.

Indexed as

PhytotherapyAnimalsAnti-Inflammatory AgentsCarrageenanChronic PainDrugs, Chinese HerbalDrug SynergismFlavonoidsInflammationInflammation MediatorsMagnoliopsidaMalePelvic PainPolysaccharidesProstateProstatitisAnti-Inflammatory AgentsCarrageenanDrugs, Chinese HerbalFlavonoidsInflammation MediatorsPolysaccharidesSaponinsAnti-inflammatoryCarrageenanChronic prostatitis/chronic pelvic pain syndromeFlavonoidPolysaccharideQian-Yu decoctionSaponin

Identifiers

PMID28122556
PMCPMC5264336
OpenAlexW2580072660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.